The administration of phyllanthin inhibited DEN-induced liver damage through caspase-dependent apoptosis via the upregulation of p53 and Bax, and the downregulation of Bcl-2, which mediates the mTOR/Akt signaling pathway and leads to the suppression of tumor initiation and progression. The gene discussed is BCL2; the disease is neoplasm.